A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

被引：0
|
作者：
P. M. Clarke
A. M. Gray
A. Briggs
A. J. Farmer
P. Fenn
R. J. Stevens
D. R. Matthews
I. M. Stratton
R. R. Holman
机构：
[1] University of Oxford,Health Economics Research Centre, Department of Public Health
[2] University of Oxford,Department of Primary Health Care
[3] University of Nottingham,Business School
[4] Churchill Hospital,Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism
[5] Churchill Hospital,Oxford Centre for Diabetes, Endocrinology and Metabolism
来源：
Diabetologia | 2004年 / 47卷
关键词：
Blood glucose; Diabetes; Diabetes-related complications; Economic evaluation; Life expectancy; Quality-adjusted life years; Risk equation simulation model; UKPDS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1747 / 1759
页数：12
相关论文
共 50 条
  • [21] The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
    King, P
    Peacock, I
    Donnelly, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (05) : 643 - 648
  • [22] Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus United Kingdom Prospective Diabetes Study (UKPDS) 79
    Davis, Timothy M. E.
    Coleman, Ruth L.
    Holman, Rury R.
    CIRCULATION, 2013, 127 (09) : 980 - +
  • [23] External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
    S. van Dieren
    L. M. Peelen
    U. Nöthlings
    Y. T. van der Schouw
    G. E. H. M. Rutten
    A. M. W. Spijkerman
    D. L. van der A
    D. Sluik
    H. Boeing
    K. G. M. Moons
    J. W. J. Beulens
    Diabetologia, 2011, 54 : 264 - 270
  • [24] External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
    van Dieren, S.
    Peelen, L. M.
    Noethlings, U.
    van der Schouw, Y. T.
    Rutten, G. E. H. M.
    Spijkerman, A. M. W.
    van der A, D. L.
    Sluik, D.
    Boeing, H.
    Moons, K. G. M.
    Beulens, J. W. J.
    DIABETOLOGIA, 2011, 54 (02) : 264 - 270
  • [25] A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes
    Tran-Duy, An
    Knight, Josh
    Palmer, Andrew J.
    Petrie, Dennis
    Lung, Tom W. C.
    Herman, William H.
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Clarke, Philip M.
    DIABETES CARE, 2020, 43 (08) : 1741 - 1749
  • [26] Association of lipid levels over time with clinical outcomes in patients with type 2 diabetes in the UKPDS
    Cull, CA
    Mehta, Z
    Stratton, IM
    Manley, SE
    Neil, A
    Holman, RR
    DIABETES, 2000, 49 : A267 - A267
  • [27] QUANTIFYING NONLINEAR EFFECTS IN STOCHASTIC MARKOV SIMULATION USING UKPDS 68 AND UKPDS 82 EQUATIONS IN TYPE 2 DIABETES MODELING ANALYSIS WITH THE IMS CORE DIABETES MODEL (CDM)
    McEwan, P.
    Grant, D.
    Lamotte, M.
    Foos, V
    VALUE IN HEALTH, 2014, 17 (07) : A546 - A546
  • [28] Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47)
    Adler, AI
    Neil, AW
    Manley, SE
    Holman, RR
    Turner, RC
    AMERICAN HEART JOURNAL, 1999, 138 (05) : S353 - S359
  • [29] Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
    Coleman, R. L.
    Gray, A. M.
    McGuire, D. K.
    Holman, R. R.
    DIABETOLOGIA, 2019, 62 : S152 - S152
  • [30] Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy
    E. Pagano
    A. Gray
    R. Rosato
    G. Gruden
    P. Cavallo Perin
    F. Merletti
    G. Bruno
    Diabetologia, 2013, 56 : 1726 - 1734
12345